Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

  • This share is currently suspended. It was suspended at a price of 0.112
  • There is currently no data for SCE

Trading Update

7 Dec 2015 07:00

RNS Number : 1267I
Surface Transforms PLC
07 December 2015
 

Surface Transforms Plc

("Surface Transforms" or the "Company")

 

Trading Update

 

Surface Transforms (AIM:SCE) is pleased to provide the following pre-close trading update, for the six months to 30 November 2015 being better than our expectations.

 

Revenue for the period was £782k (2014: £623k) being approximately 26% higher than the corresponding period last year. The Company expects that this higher revenue, will result in an EBITDA loss (inclusive of the R&D tax credit booked in the first half of the year) being significantly lower than the same period last year.

 

The increased revenue was assisted by a catch up in sales following the furnace break down in May 2015 and approximately £107k from increased aircraft revenues, but within the core automotive sales, it is encouraging to note that there was a 60% increase in retrofit car sales and a 20% increase in near OEM car sales, equivalent to approximately £100k in aggregate between the comparable half year periods; the former reflecting new additional customers, the latter being increased sales to existing customers.

 

Cash was £523k at the half year end (2014: £132k) and £829k at the year ended 31 May 2015. However net current assets increased by £266k in the period and will convert to cash over the next few months demonstrating the business being close to operating cash break-even in the first half.

 

David Bundred, Chairman, said "these better than expected results are most encouraging. Additionally at the recent AGM, the Company was able to confirm further progress on the aerospace and five game changing automotive contract discussions. The Company continues to believe it will be able to announce automotive contract awards in 2016 and that it will meet sales, EBITDA and cash useage expectations for the full year to May 2016."

 

The Company expects to report its interim results for the six months ended 30 November in February 2016.

 

Enquiries

Surface Transforms plc

Dr. Kevin Johnson, CEO

+44 151 356 2141

David Bundred, Chairman

+44 7785 388 848

 

Cantor Fitzgerald Europe

David Foreman, Michael Reynolds (Corporate Finance)

+44 207 894 7000

David Banks , Tessa Sillars (Corporate Broking)

+44 207 894 7000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPKADBFBDDKBK
Date   Source Headline
13th Nov 20234:56 pmRNSProposed Placing, Subscription and Open Offer
3rd Nov 20237:05 amRNSTrading Update
16th Oct 20237:00 amRNS£100m New Business Award from OEM 10
28th Sep 20231:55 pmEQSHardman & Co Research on Surface Transforms (SCE): Interim results
27th Sep 20237:00 amRNSInterim results for six months ended 30 June 2023
31st Jul 20237:00 amRNSPre-close trading update and operations update
20th Jul 20237:00 amRNSDirector Dealing
5th Jul 20237:00 amRNSHolding(s) in Company
27th Jun 20235:02 pmRNSResult of Annual General Meeting
27th Jun 20237:00 amRNSAGM Statement
26th Jun 20234:55 pmRNSExercise of Options and Total Voting Rights
21st Jun 20237:00 amRNSAward of LSE Green Economy Mark
20th Jun 202311:38 amRNSPDMR Dealing
19th Jun 20237:00 amRNSAppointment of new Chief Finance Officer
2nd Jun 20237:00 amRNSExercise of Options and Total Voting Rights
31st May 202312:51 pmRNSPosting of Annual Report and Notice of AGM
30th May 20237:00 amRNSAppointment of new Chief Operating Officer
23rd May 20237:00 amRNSExercise of Options and Total Voting Rights
18th May 20231:30 pmEQSHardman & Co Q&A on Surface Transforms (SCE): Production ramp up secured in a potential £2bn a year market
9th May 20237:30 amEQSHardman & Co Research on Surface Transforms (SCE): A major quantum production ramp up now secured
5th May 20237:00 amRNSDirector Dealing
27th Apr 202312:35 pmEQSHardman & Co Video | Surface Transforms (SCE) Presentation and Q&A with the Board
24th Apr 20237:00 amRNSDirector dealing and total voting rights
24th Apr 20237:00 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSPreliminary Results and Notice of AGM
6th Apr 202312:45 pmEQSHardman Talks Video Event | Surface Transforms Management Presentation and Q&A
3rd Apr 20237:00 amRNSProduction, Capacity and Trading Update
27th Jan 20232:34 pmRNSHolding(s) in Company
11th Jan 20237:00 amRNSTrading and operations update
20th Dec 20227:00 amRNSDirectorate Change
19th Dec 20227:00 amRNSPDMR Share Dealing & Total Voting Rights
15th Dec 202210:22 amEQSHardman & Co Research : Surface Transforms (SCE): Major OEM 10 order, OEM 8 delay resolved
24th Nov 20227:00 amRNSOEM 10 Contract Award and Trading Update
9th Nov 20224:42 pmRNSExercise of Options
27th Oct 202211:05 amRNSHolding(s) in Company
24th Oct 202211:15 amRNSHolding(s) in Company
20th Oct 20228:01 amRNSDirector Dealing
19th Oct 202212:23 pmRNSResult of General Meeting & Total Voting Rights
19th Oct 20227:00 amRNSResult of Open Offer
6th Oct 20222:20 pmEQSHardman & Co Research on Surface Transforms (SCE): The large growth is now self-financing
6th Oct 202212:05 pmEQSHardman & Co: Hardman Talks Video | Surface Transforms Surface Transforms presentation and Q&A with the Board
30th Sep 202211:02 amRNSInvestor Presentation
29th Sep 20221:25 pmEQSHardman & Co Research : Hardman Talks Video Event | Surface Transforms Management Presentation and Q&A
29th Sep 20228:33 amRNSResult of Placing, Open Offer Launch & GM Notice
28th Sep 20225:03 pmRNSProposed Placing, Subscription and Open Offer
12th Sep 202212:00 pmEQSHardman & Co Q&A on Surface Transforms (SCE): It's all in the detail
6th Sep 20227:15 amEQSHardman & Co Research on Surface Transforms (SCE): Further new order, upgrades, production ramp-up
5th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSContract award from OEM 9
19th Aug 20227:00 amRNSRetirement of non-executive director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.